MedTrace Logo

OsteoArthritis and Therapy for Sleep

NCT02946957 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 327

Last updated 2020-04-03

No results posted yet for this study

Summary

Osteoarthritis (OA) pain affects 50 percent of older adults, more than half of whom also experience significant sleep disturbance. This randomized trial will determine whether a telephone-based cognitive behavioral treatment targeting insomnia in older adults with chronic severe OA-related insomnia and pain results in substantially greater reductions in insomnia severity and in related improvements in pain, fatigue, mood, quality of life and healthcare costs compared to telephone-delivered education (attention control) about insomnia. The trial will test an intervention that if demonstrated to have long term efficacy is scalable and has the potential for wide-scale deployment in healthcare systems.

Conditions

  • Insomnia Related to Osteoarthritis Pain

Interventions

BEHAVIORAL

Cognitive Behavior Therapy for Insomnia

Six telephone sessions that last 20-30 minutes presenting cognitive behavioral therapy for insomnia.

BEHAVIORAL

Education Only Control

Six telephone sessions that last 20-30 minutes presenting sleep and osteoarthritis education.

Sponsors & Collaborators

Principal Investigators

  • Michael V Vitiello, PhD · University of Washington

  • Susan M McCurry, PhD · University of Washington

  • Michael Von Korff, ScD · University of Washington

  • Kai Yeung, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-12-31
Completion
2020-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02946957 on ClinicalTrials.gov